stars 1 stars 2 stars 3

Diasome Pharmaceuticals is a clinical-stage biopharmaceutical company pioneering hepatocyte cell drug targeting to restore hepatocyte metabolism and treat metabolic diseases. Diasome's Hepatocyte Targeting Platform reestablishes hepatocyte function, addressing the root cause of dysregulations central to major metabolic diseases such as diabetes, obesity, and dyslipidemia. Diasome aims to deliver superior patient outcomes and enhanced disease management by leveraging the hepatocyte's natural regulatory functions.

View Top Employees from Diasome Pharmaceuticals, Inc.

Diasome Pharmaceuticals, Inc. Questions

The Diasome Pharmaceuticals, Inc. annual revenue was $8 million in 2024.

Robert Geho is the Founder, Chief Executive Officer, Director of Diasome Pharmaceuticals, Inc..

5 people are employed at Diasome Pharmaceuticals, Inc..

Diasome Pharmaceuticals, Inc. is based in Cleveland, Ohio.

The NAICS codes for Diasome Pharmaceuticals, Inc. are [32541, 3254, 325, 32].

The SIC codes for Diasome Pharmaceuticals, Inc. are [28, 283].

Top Diasome Pharmaceuticals, Inc. Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users